Cure Genetics, a Chinese biotech startup that focuses on the treatment of cancers and genetic diseases, has secured $60 million in a Series B round of financing led by China-focused private equity (PE) firm Advantech Capital

Theranos founder Elizabeth Holmes has been convicted of defrauding investors after a months-long landmark trial in California.

The agency is expanding the use of a single booster of the Pfizer-BioNTech vaccine to children ages 12–15 and is shortening the time between primary vaccination and booster to at least five months.

Single-cell DNA sequencing firm Mission Bio said on Thursday that it has signed an agreement with China's SequMed to collaborate on services and the development of clinical applications.

On December 29, Shanghai Weihe Medical Laboratory Co., Ltd. was established with a registered capital of 1 million yuan. Equity penetration information shows that the company is indirectly wholly-owned by ByteDance.

Scientists at Scripps Research, University of Chicago and Icahn School of Medicine at Mount Sinai have identified a new Achilles’ heel of influenza virus, making progress in the quest for a universal flu vaccine.

Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, 2, 3 providing nationwide access to a new at-home or over-the-counter self-test as COVID-19 testing needs.

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc.

The research describes a new and fast computational approach to obtain precisely dated evolutionary trees, known as ‘timetrees’.

Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2021, has been completed.

Laboratory Corporation of America said Thursday that it has agreed to acquire cancer genomics firm Personal Genome Diagnostics (PGDx) for $450 million in cash and $125 million in additional payments based on future performance milestones.

On December 28,Shanghai Universal Biotech Co.,Ltd. was listed on the Shenzhen Stock Exchange (SZSE) ChiNext, stock code: 301166. The issue price is 86.06 yuan/share, and the opening price is 92 yuan/share.

Scientists at Scripps Research, University of Chicago and Icahn School of Medicine at Mount Sinai have identified a new Achilles’ heel of influenza virus, making progress in the quest for a universal flu vaccine.

Scientists have identified unique “indicators” in the blood of patients with severe and fatal COVID, paving the way for simple diagnostic tests to help doctors identify who will go on to become critically ill.

After you finish a milkshake or a bowl of guacamole, those dietary fats have a typical route through your body. New research from the laboratory of Dr. Natasza Kurpios, has now revealed a key molecular mechanism.

LumiraDx said on Thursday that it has received CE marking for its point-of-care SARS-CoV-2 & Flu A/B Antigen Test.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho

On December 15th, Ministry of Science and Technology of the People’s Republic of China announce the list of advanced collectives in the national science and technology system for fighting COVID-19 epidemic.

Co-Diagnostics said on Wednesday that it has signed definitive agreements to acquire privately held biotech firms Idaho Molecular and Advanced Conceptions for nearly $50 million in stock and warrants.

Mutations of the gene MLL4 in epithelial skin cells can inhibit healthy cell turnover and may lead to keratinocyte cancers, which collectively outnumber all other human cancers.